108 related articles for article (PubMed ID: 23067366)
1. Long-term celecoxib can prevent the progression of persistent gastric intestinal metaplasia After H. pylori eradication.
Sheu BS; Tsai YC; Wu CT; Chang WL; Cheng HC; Yang HB
Helicobacter; 2013 Apr; 18(2):117-23. PubMed ID: 23067366
[TBL] [Abstract][Full Text] [Related]
2. Short-term celecoxib to regress long-term persistent gastric intestinal metaplasia after Helicobacter pylori eradication.
Hung KH; Yang HB; Cheng HC; Wu JJ; Sheu BS
J Gastroenterol Hepatol; 2010 Jan; 25(1):48-53. PubMed ID: 19793174
[TBL] [Abstract][Full Text] [Related]
3. Predictive factors for improvement of atrophic gastritis and intestinal metaplasia after Helicobacter pylori eradication: a three-year follow-up study in Korea.
Kang JM; Kim N; Shin CM; Lee HS; Lee DH; Jung HC; Song IS
Helicobacter; 2012 Apr; 17(2):86-95. PubMed ID: 22404438
[TBL] [Abstract][Full Text] [Related]
4. Chronic celecoxib users more often show regression of gastric intestinal metaplasia after Helicobacter pylori eradication.
Yang HB; Cheng HC; Sheu BS; Hung KH; Liou MF; Wu JJ
Aliment Pharmacol Ther; 2007 Feb; 25(4):455-61. PubMed ID: 17270001
[TBL] [Abstract][Full Text] [Related]
5. Helicobacter pylori eradication improves gastric atrophy and intestinal metaplasia in long-term observation.
Kodama M; Murakami K; Okimoto T; Abe T; Nakagawa Y; Mizukami K; Uchida M; Inoue K; Fujioka T
Digestion; 2012; 85(2):126-30. PubMed ID: 22269293
[TBL] [Abstract][Full Text] [Related]
6. Eradication of Helicobacter pylori infection improved gastric mucosal atrophy and prevented progression of intestinal metaplasia, especially in the elderly population: a long-term prospective cohort study.
Toyokawa T; Suwaki K; Miyake Y; Nakatsu M; Ando M
J Gastroenterol Hepatol; 2010 Mar; 25(3):544-7. PubMed ID: 19817964
[TBL] [Abstract][Full Text] [Related]
7. A follow-up study of atrophic gastritis and intestinal metaplasia after eradication of Helicobacter pylori.
Satoh K; Kimura K; Takimoto T; Kihira K
Helicobacter; 1998 Dec; 3(4):236-40. PubMed ID: 9844064
[TBL] [Abstract][Full Text] [Related]
8. H. pylori eradication prevents the progression of gastric intestinal metaplasia in reflux esophagitis patients using long-term esomeprazole.
Yang HB; Sheu BS; Wang ST; Cheng HC; Chang WL; Chen WY
Am J Gastroenterol; 2009 Jul; 104(7):1642-9. PubMed ID: 19436275
[TBL] [Abstract][Full Text] [Related]
9. Effects of selective COX-2 inhibitor and Helicobacter pylori eradication on precancerous gastric lesions.
Wong BC; Zhang L; Ma JL; Pan KF; Li JY; Shen L; Liu WD; Feng GS; Zhang XD; Li J; Lu AP; Xia HH; Lam S; You WC
Gut; 2012 Jun; 61(6):812-8. PubMed ID: 21917649
[TBL] [Abstract][Full Text] [Related]
10. Gastric atrophy and intestinal metaplasia before and after Helicobacter pylori eradication: a meta-analysis.
Wang J; Xu L; Shi R; Huang X; Li SW; Huang Z; Zhang G
Digestion; 2011; 83(4):253-60. PubMed ID: 21282951
[TBL] [Abstract][Full Text] [Related]
11. Precancerous conditions after H. pylori eradication: a randomized double blind study in first degree relatives of gastric cancer patients.
Massarrat S; Haj-Sheykholeslami A; Mohamadkhani A; Zendehdel N; Rakhshani N; Stolte M; Mirzaei M; Saliminejhad M; Saeidi S; Shahidi M
Arch Iran Med; 2012 Nov; 15(11):664-9. PubMed ID: 23102241
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of gastric microbiome and metagenomic function in patients with intestinal metaplasia using 16S rRNA gene sequencing.
Park CH; Lee AR; Lee YR; Eun CS; Lee SK; Han DS
Helicobacter; 2019 Feb; 24(1):e12547. PubMed ID: 30440093
[TBL] [Abstract][Full Text] [Related]
13. Randomised clinical trial: the effects of Helicobacter pylori eradication on glandular atrophy and intestinal metaplasia after subtotal gastrectomy for gastric cancer.
Cho SJ; Choi IJ; Kook MC; Yoon H; Park S; Kim CG; Lee JY; Lee JH; Ryu KW; Kim YW
Aliment Pharmacol Ther; 2013 Sep; 38(5):477-89. PubMed ID: 23822578
[TBL] [Abstract][Full Text] [Related]
14. Helicobacter pylori eradication in the healing of atrophic gastritis: a one-year prospective study.
Arkkila PE; Seppälä K; Färkkilä MA; Veijola L; Sipponen P
Scand J Gastroenterol; 2006 Jul; 41(7):782-90. PubMed ID: 16785190
[TBL] [Abstract][Full Text] [Related]
15. [Intestinal metaplasia and Helicobacter pylori infection, their relationship and effects of eradication therapy].
Sakaki N; Kozawa H
Nihon Rinsho; 2001 Feb; 59(2):361-6. PubMed ID: 11218413
[TBL] [Abstract][Full Text] [Related]
16. Helicobacter pylori eradication and antral intestinal metaplasia--two years follow-up study.
Ciok J; Dzieniszewski J; Lucer C
J Physiol Pharmacol; 1997 Sep; 48 Suppl 4():115-22. PubMed ID: 9440062
[TBL] [Abstract][Full Text] [Related]
17. Higher gastric cycloxygenase-2 expression and precancerous change in Helicobacter pylori-infected relatives of gastric cancer patients.
Sheu BS; Yang HB; Sheu SM; Huang AH; Wu JJ
Clin Cancer Res; 2003 Nov; 9(14):5245-51. PubMed ID: 14614005
[TBL] [Abstract][Full Text] [Related]
18. [The assessment of nitric oxide metabolites in gastric juice in Helicobacter pylori infected subjects in compliance with grade of inflammatory lesions in gastric mucosa].
Walecka-Kapica E; Knopik-Dabrowicz A; Klupińska G; Chojnacki J
Pol Merkur Lekarski; 2008 Feb; 24(140):95-100. PubMed ID: 18634262
[TBL] [Abstract][Full Text] [Related]
19. [Histological changes of gastric atrophy and intestinal metaplasia after Helicobacter pylori eradication].
Lee Y; Jeon YC; Koo TY; Cho HS; Byun TJ; Kim TY; Lee HL; Eun CS; Lee OY; Han DS; Sohn JH; Yoon BC
Korean J Gastroenterol; 2007 Nov; 50(5):299-305. PubMed ID: 18159161
[TBL] [Abstract][Full Text] [Related]
20. Celecoxib compared with lansoprazole and naproxen to prevent gastrointestinal ulcer complications.
Lai KC; Chu KM; Hui WM; Wong BC; Hu WH; Wong WM; Chan AO; Wong J; Lam SK
Am J Med; 2005 Nov; 118(11):1271-8. PubMed ID: 16271912
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
